Medical use of pharmaceutical combination or composition
US10155000B2 · kind B2 · utility
11Cited by
152References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2017 |
| Grant date | Dec 18, 2018 |
| Priority date | — |
| Expiry date | Jun 8, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a certain DPP-4 inhibitor for use in combination with metformin in CKD patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.